JSW Cement Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹1,912 Cr (+33% YoY) was volume-led, while operating EBITDA rose only 4% YoY to ₹278 Cr on price softness and fuel inflation. North turned marginally EBITDA-positive.
ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
7,889 announcements with these filters
Consolidated revenue ₹1,912 Cr (+33% YoY) was volume-led, while operating EBITDA rose only 4% YoY to ₹278 Cr on price softness and fuel inflation. North turned marginally EBITDA-positive.
Q2 FY27 consolidated revenue ₹136.3 Cr (+110% YoY, +45% QoQ) and PAT ₹11.8 Cr, the first group profit quarter, led by Innoxel. Standalone margins squeezed by input costs; FY27 guidance maintained.
Sharda Cropchem delivered double-digit revenue growth and margin expansion, led by strong performance in NAFTA and LATAM, despite European weather headwinds and volume de-growth.
LCC Projects reports a strong Q2 with 34% revenue growth, though high receivables (₹674 Cr) signal working capital strain.
Q2FY27: AUM ₹1,627 Cr (+16% YoY), record disbursements ₹385 Cr (+31% YoY), NII ₹49.6 Cr (+21% YoY), PAT ₹25.0 Cr (+2% YoY). Wholesale-led growth; SME Retail recovering gradually.
Q2 FY27 consolidated revenue ₹3,897 Cr (+13%), EBITDA ₹709 Cr (+27%), PAT ₹550 Cr (+31%); volume-led growth with Foods and Premium Personal Care scaling.
Q2FY27 revenue Rs 407.3 Cr (+4.6% YoY, +16.4% QoQ); operating EBITDA margin 7.5% vs 10.2% YoY; reported PAT -Rs 0.6 Cr. Retail volume growing; exports resuming.
Updater Services reported healthy Q2 results with revenue growing 11% YoY, driven by margin expansion across IFM and BSS segments.
Management reports a modest and subdued quarter due to high fuel prices and depressed pricing in central India.
Q2FY27 revenue ₹1,113 Cr (+58% YoY), PAT ₹30 Cr (+87%), EBITDA margin 6.21% (vs 7.10%). Record revenue; order book ₹12,872 Cr; precast capacity expansion underway.
Sai Parenterals is transitioning from a standalone unit to a consolidated manufacturing and R&D powerhouse through strategic acquisitions. While revenue grew 9% sequentially, high depreciation from new assets is currently masking operating profitability gains.
Q2 FY27 revenue ₹1,513 Cr (+14%), PBDIT ₹91 Cr (-11%), PAT ₹39.6 Cr (-20%); commodity and forex costs compress margins.
Q2FY27 revenue ₹11,860 cr (-1%), EBITDA ₹2,312 cr (+5%, 19.5% margin); H1 Operational PATMI ₹441 cr (+33%). Eight quarters of margin expansion; Advanta acquiring Misr Hytech.
Q2 FY27 revenue up 3% YoY to INR 2,558 Mn; EBITDA up 27% to 406 Mn (15.9% margin); PAT up 24% to 257 Mn. H1 revenue down 3%.
Revenue fell 21% YoY due to erratic monsoon and deliberate generic reduction, yet margins expanded significantly.
Q2FY27 standalone revenue ₹3,231.4 Cr (+16.3% YoY), EBITDA margin 9.0% (-403 bps), PAT ₹255.0 Cr (-20.6%). Tractor volumes flat; construction equipment volumes +53.9%.
H1FY27 consolidated revenue Rs 929.26 Cr (+46% YoY), PAT Rs 79.22 Cr (+35%), EBITDA margin 12.02%. Strategy: T&D EPC, BESS, GEC-III pipeline.
Management maintains expansion optimism despite inflation and seasonality pressures affecting brand margins.
Q2 FY27 revenue Rs274.23 Cr (+31% YoY), PAT Rs21.07 Cr (+36%), EBITDA Rs51.27 Cr (+30%) at 18.70% margin. H1 revenue +28%, PAT +23%.
Q2 FY27 revenue Rs197 Mn, EBITDA Rs23 Mn (11.4% margin), reported PAT loss Rs26 Mn; adj. PAT Rs1 Mn. H1 revenue Rs410 Mn, EBITDA margin 11.5%.
Q2 FY27 consolidated EBITDA ₹564 Cr (-2.7% YoY), PAT ₹320 Cr (-2.2%). Record H1 EBITDA ₹1,326 Cr (+3.9%); manganese mine won, 2x EBITDA roadmap.
H1 FY27 revenue of ₹43.72 Cr (+72.64% YoY) and PAT of ₹3.54 Cr versus a prior loss. Margins were deliberately sacrificed for marketing and the distributor transition. Debtor days (219) and cash (₹1.05 Cr) are the key weak spots.
Q2FY27 consolidated revenue Rs 2,474 Cr (+14% YoY), EBITDA Rs 310 Cr (+12%), PAT Rs 74 Cr (+20%). Strategy: Carbon Black scale-up, Aquapharm specialty growth, advanced battery materials.
Aarti achieved record quarterly EBITDA but faces ballooning debt and working capital stress due to raw material inflation. Management is pivoting from heavy capex to asset sweating and deleveraging via a ₹1,000 Cr fundraise.
Lodha delivered record H1 performance with 63% PAT growth, though management relies heavily on second-half momentum and large one-time data center land sales to beat their 20% annual profit growth guidance.
Q2FY27 revenue ₹752 Cr (+28% YoY) and PAT ₹64 Cr (+26%). EBITDA margin fell to 18% (23% YoY) on raw material costs. Derivatives & Specialty now 57% of revenue. CPVC and ECH capacity due Q3FY27.
Record Q2 performance driven by global expansion and operational stabilization of new facilities in Sangli and Turkey.
Q2 FY27 revenue from operations ₹2,957 Mn; record EBITDA ₹227 Mn (7.5% margin); PAT ₹118 Mn, fourth straight profitable quarter, driven by GMV growth and margin expansion.
H1 FY27 revenue ₹134.31 cr (+162% YoY), EBITDA ₹9.98 cr at 7.4% margin, PAT ₹3.30 cr vs prior loss. GCC-led turnaround; targets 5x revenue and 10x EBITDA by FY29.
Q2 FY27 revenue ₹4,293 Mn (+40.9% YoY), SSSG +24.5%, dine-in volumes +56.2%. Reported net loss narrowed to ₹64 Mn; adjusted operating EBITDA margin 6.1%. Network 274 restaurants, targeting 300+ by FY27.